Form D · Biotechnology

ImmuneXcite, Inc.

Waltham, MA · CIK 0001538550

Offering snapshot reported Feb 1, 2017 · SEC filing

Reported sold
$8.92M
Offering amount: $10.9M
Investors reported
81
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 25, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.46M$8.92MDec 10, 2015: $5,761,038.00Dec 10, 2015Apr 6, 2016: $6,967,501.00Apr 6, 2016Feb 1, 2017: $8,920,848.00Feb 1, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,967,501 → $8,920,848
  • Reported investors72 → 81

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 1, 2017Amendment$8,920,848$1,953,347vs Apr 6, 201681SEC filing
Feb 1, 2017Initial$2,672,359No comparison47SEC filing
Apr 6, 2016Amendment$6,967,501$1,206,463vs Dec 10, 201572SEC filing
Dec 10, 2015Initial$5,761,038No comparison64SEC filing
Jan 6, 2014Initial$3,579,950No comparison51SEC filing
Jan 3, 2012Initial$2,418,788No comparison36SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-252821

Source: Form D, filed Feb 1, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yaniv Bejerano Director, Executive
Ann De Witt Director
John Edwards Director, Executive
Valerie Friedman Director
Eric Furfine Director, Executive
James Geraghty Director
Stonberg Jeff Director
Eric Rowinsky Director
David Schechter Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
266 2nd Avenue Suite C
Waltham, MA, 02451